4th Quarter - Report

DLA PIPER LLP (US) for HUMACYTE, INC.

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

S. 4921, Department of Defense Appropriations Act, FY2025, provisions related to biologic vascular research. S. 4638, National Defense Authorization Act for FY2025, provisions related to biologic vascular research.

LobbyistCovered position, as disclosed
MICHAEL SORENSEN —

Contacted: SENATE

Bills named: S. 4921 (118th), S. 4638 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.